Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
FDA
to review CombinatoRx drug application 8:05 AM 9/22/2009
Bizjournals.com
CombinatoRx Inc said the US FDA is set to review its new drug application for
its pain medication Exalgo to be used around-the-clock by patients with moderate-to-severe pain and tolerance to
other traditional pain medications.
...
Oxford
Bio's failed cancer vaccine may help some 4:36 AM 9/22/2009
Reuters
Oxford BioMedica's failed therapeutic cancer vaccine TroVax may still help
a subset of patients. Patients with a good prognostic profile receiving interleukin-2 therapy did live longer.
...
King
Pharma says it launched pain drug Embeda 1:33 PM 9/21/2009
Forbes
King Pharmaceuticals launched pain drug Embeda designed to be
abuse-resistant. Crushing or chewing releases naltrexone which wrecks the high from morphine.
...
Celsion
to continue liver cancer drug study 11:54 AM 9/21/2009
Forbes
Celsion Corp said its data monitoring safety board recommended continued enrollment in a
late-stage study for the potential liver cancer treatment ThermoDox.
...
Vitae
begins hypertension drug study 10:11 AM 9/21/2009
Bizjournals.com
Vitae Pharmaceuticals Inc initiated a phase-I clinical trial of its experimental
hypertension drug VTP-27999.
...
Impax
Pharmaceuticals Reports Positive Results of Phase II Trial
... 9:28 AM 9/21/2009
Reuters
Impax
Laboratories Inc reported positive results from a recently completed Phase II trial of its late-stage Parkinson`s
Disease drug candidate IPX066.
...
Neuralstem
gets FDA OK to test stem cell drug in humans 8:29 AM 9/21/2009
Reuters
Neuralstem Inc said the US FDA allowed the start of an early-stage human
trial of its spinal cord stem cells in Lou Gehrig's disease.
...
Amgen's
new bone drug helps in mixed tumor study 7:15 AM 9/21/2009
Reuters
Amgen's experimental bone-strengthening drug denosumab helped patients with
a mix of advanced cancer types. Denosumab was as effective as Novartis's Zometa in delaying time to fracture or
other skeletal-related events (SREs).
...
AstraZeneca
Licenses Two Drugs From Nektar Therapeutics 4:52 AM 9/21/2009
Wall Street Journal
AstraZeneca said it licensed NKTR-118 and NKTR-119 drugs for
painkiller-induced constipation from Nektar Therapeutics.
...
Bayer,
Onyx drug impresses in breast cancer study 3:32 AM 9/21/2009
Reuters
Bayer and Onyx Pharmaceuticals's cancer pill Nexavar has demonstrated good
results treating breast tumors.
...
Obama:
First family to follow rules on flu vaccine 8:06 AM 9/20/2009
The Associated Press
Unless something bad happens. Vaccine given first to pregnant
people, those living with or caring for kids under 6 months, health care workers, ages 6 months through 24, and
people with chronic health problems or compromised immune systems.
...
CDC Unveils Distribution Plan for H1N1 Influenza Vaccine 4:25 PM
9/18/2009
Washington Post
Pandemic H1N1 influenza vaccine will be
distributed from four regional warehouses next month. There will be 20 million doses delivered each week by the
end of October distributed among 90,000 immunization providers.
...
Flu Vaccine Shares to
Fall as H1N1 Gets Contained 12:17 PM 9/18/2009
Bloomberg
Hualan Biological Engineering Inc and Sinovac Biotech Ltd may give up stock gains once
governments contain the H1N1 virus.
...
Ten
Things To Know About H1N1 4:53 AM 9/18/2009
CBS
News
The Centers for Disease Control and Prevention provides useful information.
...
Arena
Reports Obesity Drug Success, But Data May
Disappoint 3:23 AM 9/18/2009
Wall Street
Journal
Arena Pharmaceuticals Inc reported the success of its second large late-stage study of
weight-loss drug lorcaserin. Arena is in a three-way race with Vivus Inc and Orexigen Therapeutics Inc.
...
<- Day Earlier | Today's News
|
